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Introduction
The 2011 IEEE International Workshop on Genomic
Signal Processing and Statistics (GENSIPS 2011) was
organized in San Antonio, Texas from December 2-4th.
GENSIPS’11 provided a forum for researchers in the sig-
nal processing community, other related computational
experts, and biomedical scientists to exchange ideas and
discuss signal processing challenges due to the high
modality of disparate high-throughput data, high varia-
bility of the data acquisition, high dimensionality of
data, and high complexity of genomics and proteomics
systems. The theme of GENSIPS’11 was cancer and com-
putational biology and GENSIPS featured prominent plen-
ary speakers including Dr. John N. Weinstein from UT
MD Anderson Cancer Center, Dr. Stephen Wong from
Methodist Hospital at Cornell University, Dr. David
Nelson from Baylor College of Medicine and Dr. Chung-I
Wu from the Beijing Institute of Genomics.
Articles
This supplement contains extended versions of selected
articles from GENSIPS conference proceedings. Each
submitted article to the conference was reviewed by a
minimum of two reviewers and the top twenty favorably
reviewed papers from sixty selected papers (33%) were
invited to submit the extended versions for this supple-
ment. The extended journal versions were further
reviewed according to rigorous peer-review criteria.
The accepted articles can be broadly categorized into
four groups:
Gene network inference and cancer therapy design
Models of genetic regulatory networks can belong to the
class of deterministic or stochastic, discrete or continu-
ous, fine-scale or coarse-scale quantitative models. The
availability of experimental data, prior biological knowl-
edge and purpose of modeling frequently guide the
selection of the quantitative model to represent the
biological network. Sridharan et al. [1] provides an
approach for Boolean modeling and analysis of the oxi-
dative stress response pathway based on prior biological
knowledge. Oxidative stress has been implicated in a
variety of diseases including, but not limited to aging
and age-related diseases such as cancer, cardiovascular
disease, chronic inflammation, and neurodegenerative
disorders. Lin and Khatri [2] considers the aberrant
behavior of signaling pathways during cancer as faults in
an electronic circuit and presents a Max-SAT based
automatic test pattern generation (ATPG) algorithm for
cancer therapy. In Haider and Pal [3], a Boolean
Network inference algorithm from limited time series
data utilizing prior biological knowledge on connectivity
is presented. The algorithm is validated on synthetic
data and experimental transcriptomic measurements
from Human Mammary Epithelial Cell line. As compared
to two existing Boolean network inference approaches,
the proposed algorithm performs better in terms of
robustness and estimation of state transitions. Wu et al.
[4] provides a linear regression approach to model tran-
scription regulation following estrogen stimulation in
breast cancer cells. The proposed technique is validated
using gene expression and ERa Chip-seq data from the
MCF-7 cell line. Fine-scale modeling of genetic regula-
tory networks using stochastic master equation models
entails a huge computational complexity and Karim et al.
[5] presents a computationally inexpensive way to
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generate the steady state distributions for stochastic mas-
ter equation models. In Wang et al. [6], a quantitative
mathematical model to predict macrophage activation
patterns following myocardial infarction is reported. The
model was validated on experimental data from adult
C57 mice. A single type of genomic data is typically not
suitable to understand regulation of cell behavior. Vice-
nte et al. [7] presents an approach to assess the gain in
predictive performance by integrating various types of
biological information in network inference.
Genomic data analysis
For analysis of DNA methylation profiles, Zhang et al. [8]
presents a non-parametric infinite beta mixture model to
cluster DNA methylation expression profiles produced
by Illumina Infinium Beadchip. For genome-wide asso-
ciation studies (GWAS), Jia and Zhao [9] applies a dense
module search algorithm for locating network modules
that are jointly associated with a disease. A restricted
search approach is applied for reducing the computa-
tional complexity and the strategy is demonstrated on
CATIE GWAS dataset for schizophrenia. Taslim et al.
[10] proposes a quantitative approach using mixture
models to characterize patterns of promoter regions and
predict novel and alternative promoters. Jahid and Ruan
[11] proposes a method for biomarker discovery by com-
bining microarray gene expression profiles and protein-
protein interaction networks.
Prediction of drug effectiveness
Targeted cancer therapy is considered to be a cornerstone
for personalized medicine. Research problems in this area
include understanding and modeling the mechanisms of
action of molecularly targeted drugs and design of combi-
nation drug therapies. Li et al. [12] presents an integrated
experimental and theoretical approach to investigate the
mechanism of action and identify pharmacodynamic char-
acteristics of targeted agents based on cell-line platforms.
Specifically, tumor cell response is analyzed via the use of
fluorescent reporters; dynamics of drug efficacy for differ-
ent dosages are studied using dynamic modeling; and
time-varying parameters are estimated using system iden-
tification techniques. Lin et al. [2] proposes to predict the
ffectiveness of targeted drugs and guide drug selection by
modeling the cancer pathway as a Boolean circuit. Kim
and Yoon [13] presents an adaptive reference update
(ARU) algorithm to search for the optimal drug combina-
tion by comparing the response of the current combina-
tion against that of the reference combination and
beneficially updating the drug concentrations. Application
to real and synthetic examples shows that the ARU algo-
rithm outperforms existing algorithms in terms of effec-
tiveness, efficiency, and robustness.
Analysis workflows
Advancement in measurement technologies provides vast
quantities of experimental data on various components of
the regulome. This requires new approaches for the sys-
tematic generation and analysis of the experimental data.
For large-scale protein profiling, Sun et al. [14] provides
an integrative model for Liquid Chromatography coupled
Mass Spectrometry, and apply it to the systematic analy-
sis of key factors that impact the number of identified
peptides and quantified proteins, protein quantification
error, differential expression results, and classification
performance. The presence of extraneous variables
caused by the sample variability can significantly affect
the statistical analysis of high-throughput genetic data.
Hsu et al. [15] proposes a novel approach using batch
effect correction, a sample selection process, and a semi-
supervised clustering method for reducing the confound-
ing and suppression effects induced by the extraneous
variables. Rodriguez et al. [16] presents an analysis work-
flow that permits researchers to compare DNA methyla-
tion profiles across multiple biological or patient groups.
Comparisons can be made at particular regions of a chro-
mosome or across the genome as a whole. This workflow
and its suite of features can assist biomedical scientists in
conducting methylation profiling projects and facilitate
meaningful biological interpretation of their data. Charac-
terizing copy-number variation is a basic method to pro-
file normal and diseased tissue samples, but challenges
remain in accurately interpreting the data from a single
genome and comparative measurements from groups of
sequenced genomes. Janevski et al. [17] studies several
variations of copy-number analysis approaches to assess
the significance and impact of each methodology choice.
Huang et al. [18] proposes C2Maps platform as an online
bioinformatics resource providing biologists with direc-
tional relationships between drugs and genes/proteins in
specific disease contexts based on network mining, litera-
ture mining, and drug effect annotations. Doderer et al.
[19] analyzes pathway consolidation approaches and pro-
vides a user-friendly web-accessible tool that can enable
users to extract functional relations of genes across multi-
ple pathway databases. A case study of performing perso-
nal genome analysis on a cloud computing environment
is presented in Evani et al. [20]. The approach can assist
researchers in applying existing cloud computing technol-
ogies to analyze enormous amount of data generated by
next-generation sequencing technologies.
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